Reuters Health Medical News

Reuters Health Medical News is a comprehensive source of global medical and pharmaceutical sector news. Each Reuters Health news story is written by Reuters Health's own team of specialized medical and healthcare journalists, all of whom have a medical, pharmaceutical, or life science background.

Reuters Health Medical News includes coverage of

• Pharmaceutical and Device R&D
• Drug Pipeline Developments
• Clinical Trials
• Medical & Disease Research
• Epidemiology
• Diagnostics
• Scientific Breakthroughs
• Drug Discovery
• Genetics/Genomics
• Biotechnology
• Drug Safety
• ADRs

These stories run across all major therapeutic categories, including but not limited to: Oncology, Cardiology, Neurology, Mental Health, Respiratory, Obesity, Diabetes, HIV/AIDS, Infectious Diseases, Women's Health and OB/GYN, Men's Health, Pediatrics, Geriatrics, Gastro, Urology, Fertility, Surgery, Public Health and Pain Management issues.

Primary sources of Reuters Health Medical News include:

• pre-publication embargoed copies of over 200 key peer-reviewed international medical journals;
• coverage of between 50-100 major international medical conferences and symposia each year;

countless government reports, press releases, and briefings from key healthcare stakeholders (such as medical associations, research institutes, pharmaceutical companies; medical charities and hospitals).